A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

Henrik Barth; Sven Crafoord; Sten Andréasson; Fredrik Ghosh

doi:10.1007/s00417-015-3256-z

A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

Henrik Barth, Sven Crafoord, Sten Andréasson, Fredrik Ghosh

Ophthalmology, Lund

Research output: Contribution to journal › Article › peer-review

Abstract

Vitrectomy requires the substitution of the natural vitreous, as well as tamponading of retinal breaks. Clinically available alternatives such as gas and silicone oil have side effects such as inflammation, secondary glaucoma, cataract, and a need for head posturing. In this study, a hydrogel of cross-linked sodium hyaluronic acid (Healaflow(®)) is evaluated for use as a novel vitreous substitute.

Original language	English
Journal	Graefe's Archive for Clinical and Experimental Ophthalmology
Early online date	2016 Jan 8
DOIs	https://doi.org/10.1007/s00417-015-3256-z
Publication status	Published - 2016

Subject classification (UKÄ)

Ophthalmology

Access to Document

10.1007/s00417-015-3256-z

http://www.ncbi.nlm.nih.gov/pubmed/26743755?dopt=Abstract

1 Doctoral Thesis (compilation)

Experimental Vitreous Substitution
Barth, H., 2018, Lund: Lund University: Faculty of Medicine. 91 p.
Research output: Thesis › Doctoral Thesis (compilation)

File

Cite this

@article{f6ebc8a0966c46d6970d9e0ca7238a4f,

title = "A cross-linked hyaluronic acid hydrogel (Healaflow({\textregistered})) as a novel vitreous substitute.",

abstract = "Vitrectomy requires the substitution of the natural vitreous, as well as tamponading of retinal breaks. Clinically available alternatives such as gas and silicone oil have side effects such as inflammation, secondary glaucoma, cataract, and a need for head posturing. In this study, a hydrogel of cross-linked sodium hyaluronic acid (Healaflow({\textregistered})) is evaluated for use as a novel vitreous substitute.",

author = "Henrik Barth and Sven Crafoord and Sten Andr{\'e}asson and Fredrik Ghosh",

year = "2016",

doi = "10.1007/s00417-015-3256-z",

language = "English",

journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",

issn = "1435-702X",

publisher = "Springer",

}

TY - JOUR

T1 - A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

AU - Barth, Henrik

AU - Crafoord, Sven

AU - Andréasson, Sten

AU - Ghosh, Fredrik

PY - 2016

Y1 - 2016

N2 - Vitrectomy requires the substitution of the natural vitreous, as well as tamponading of retinal breaks. Clinically available alternatives such as gas and silicone oil have side effects such as inflammation, secondary glaucoma, cataract, and a need for head posturing. In this study, a hydrogel of cross-linked sodium hyaluronic acid (Healaflow(®)) is evaluated for use as a novel vitreous substitute.

AB - Vitrectomy requires the substitution of the natural vitreous, as well as tamponading of retinal breaks. Clinically available alternatives such as gas and silicone oil have side effects such as inflammation, secondary glaucoma, cataract, and a need for head posturing. In this study, a hydrogel of cross-linked sodium hyaluronic acid (Healaflow(®)) is evaluated for use as a novel vitreous substitute.

U2 - 10.1007/s00417-015-3256-z

DO - 10.1007/s00417-015-3256-z

M3 - Article

C2 - 26743755

SN - 1435-702X

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

ER -

A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Research output

Experimental Vitreous Substitution

Cite this